American Cancer Society

Red Roof® Partners with Canine Companions® Offering Traveler Savings and Helping to Transform Lives

Retrieved on: 
Thursday, February 1, 2024
Partnership, United States Army, Anxiety, Disability, The Room, Canine, Red, Room, DNA, Nightmare, Dog, American Cancer Society, Hypervigilance, Marketing, Walla, United Way, Post-traumatic stress disorder, Thurgood Marshall College, Veteran, Organization, Vaccine

Canine Companions' expertly trained service dogs make a world of difference by empowering Canine Companions' clients to lead lives with enhanced independence.

Key Points: 
  • Canine Companions' expertly trained service dogs make a world of difference by empowering Canine Companions' clients to lead lives with enhanced independence.
  • Canine Companions believes, and Red Roof agrees, that independence shouldn't be limited to those who look or live a certain way.
  • "Over the past three years, Red Roof has donated more than $100,000 to Canine Companions."
  • Canine Companions transforms the lives of people with disabilities by providing their clients with expertly trained service dogs, free of charge.

Lyre's Non-Alcoholic & Ezy Raise Launch the inaugural "Dry Feb™️" Fundraising Challenge to Benefit American Cancer Society

Retrieved on: 
Wednesday, January 31, 2024
Partnership, Grand Central Terminal, American Cancer Society, Dry, Lyre, Drinking, Disease, Cancer, Health, ACS, Motivation, Woman, Dietary supplement

NEW YORK, Jan. 30, 2024 /PRNewswire/ -- Dry Feb™️ is a partnership between Lyre's, the world's best-selling non-alcoholic brand, and Ezy Raise, the team that raised over $150 million to support people affected by cancer around the world, to benefit the American Cancer Society. Almost everyone knows someone who's been impacted by cancer and a growing body of evidence links alcohol to many types of the disease. With 1 in 2 men, and 1 in 3 women in America expected to face a cancer diagnosis in their lifetime, this coalition has come together to rally their communities behind mindful drinking and the fight against cancer.  Dry Feb™️ asks participants to commit to one month without alcohol and provides the opportunity for participants to raise money and improve the lives of people impacted by cancer.

Key Points: 
  • Almost everyone knows someone who's been impacted by cancer and a growing body of evidence links alcohol to many types of the disease .
  • Dry Feb™️ asks participants to commit to one month without alcohol and provides the opportunity for participants to raise money and improve the lives of people impacted by cancer.
  • To sign-up or learn more about the Dry Feb challenge and the health benefits (such as sleeping better and increased energy), head to dryfeb.com .
  • Brand representatives for Lyre's and the ACS will be on-site to share more information about this powerful new initiative.

Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

Retrieved on: 
Wednesday, January 24, 2024
Death, Neoplasm, Patient, Nanoparticle, Therapy, Ras GTPase, RNA, Small RNA, Cancer, NSCLC, Mutation, IND, Lung cancer, FDA, Investigational New Drug, CRC, Clinical trial, Colorectal cancer, Patent, RAS, American Cancer Society

HAMILTON, BERMUDA, Jan. 24, 2024 -- Altamira Therapeutics Ltd. (Nasdaq: CYTO) ("Altamira" or the "Company"), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, today announced that it has filed a second provisional patent application with the United States Patent and Trade Office (USPTO) to provide broad coverage of different KRAS mutations in human cancer treatment with nanoparticles comprising the Company’s OligoPhore™ platform and a single siRNA sequence, polyKRASmut. The nanoparticles are developed by Altamira as AM-401.

Key Points: 
  • The second provisional application contains in vitro data confirming the ability of polyKRASmut siRNA to knock down a broad range of KRAS mutations in cancer cell lines.
  • Since polyKRASmut was tested against only a limited number of mutations, it may potentially knock down other, yet untested mutations.
  • “By combining the polyKRASmut siRNA with our OligoPhore platform we can direct its delivery to the tumor and tackle with one single compound many different KRAS mutations.
  • Only recently, the FDA approved the first two treatments for KRAS-driven cancer: sotorasib and adagrasib, two small molecule inhibitors of G12C-mutated KRAS for the treatment of NSCLC.

The International Myeloma Foundation Mourns the Passing of IMF Board Member Dr. Edith Mitchell

Retrieved on: 
Tuesday, January 23, 2024
Mentorship, Research, Principal, City, IMF, Internal medicine, AACR, Cancer, NCI, Public key certificate, FACC, Multiple myeloma, International Myeloma Foundation, National Cancer Institute, MACP, ECOG, African Americans, Medical college, Air force, National Medical Association, Breast, Health equity, Student, American Cancer Society, Radiation therapy, Thomas Jefferson University, Blue-ribbon committee, Military, NMA, Air National Guard, Human, FCPP, Oncology, Patient, Sadness, Partnership, ASCO, Distinguished Service Award, Friends, Society, Travel, LAPS, FRCP, Alpha Kappa Alpha, Clinical trial, Nursing

Dr. Edith Mitchell has been a member of the IMF Board of Directors for over twenty years.

Key Points: 
  • Dr. Edith Mitchell has been a member of the IMF Board of Directors for over twenty years.
  • In 2023, Dr. Mitchell received the Pennsylvania Medical Society’s (PAMED) Distinguished Service Award—the highest award presented by PAMED.
  • Edith Mitchell’s passing is such a profound loss for the IMF, the IMF Board of Directors, and the myeloma community at large.
  • The International Myeloma Foundation sends its deepest sympathies, thoughts, and prayers to Dr. Mitchell’s family members, friends, colleagues, and loved ones.

Solis Mammography and MountainStar Healthcare Announce Strategic Partnership to Enhance Women’s Health in Utah

Retrieved on: 
Thursday, January 18, 2024
Woman, Mammography, Health, Partnership, Standard of care, Breast cancer, HCA Healthcare, Timpanogos Regional Hospital, American Cancer Society, Birth control

Addison, TX, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Solis Mammography , the nation’s largest independent provider of specialized breast health services, is pleased to announce a groundbreaking new partnership with MountainStar Healthcare, a division of HCA Healthcare, to extend its industry-leading expertise and superior care to the women of Utah.

Key Points: 
  • Addison, TX, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Solis Mammography , the nation’s largest independent provider of specialized breast health services, is pleased to announce a groundbreaking new partnership with MountainStar Healthcare, a division of HCA Healthcare, to extend its industry-leading expertise and superior care to the women of Utah.
  • With a strong commitment to women’s health, Solis Mammography has been a trailblazer in the field of breast imaging for almost 40 years, serving women in major markets across the country.
  • Utah currently faces a challenge with low mammography compliance rates, highlighting the critical need for increased awareness and easy accessibility to advanced breast health services.
  • “Our journey with MountainStar Healthcare is focused on the patient,” said Grant Davies, President and Chief Executive Officer of Solis Mammography.

aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor

Retrieved on: 
Thursday, January 18, 2024
Mortality, ILD, Patient, Outline of health sciences, Wayne A. I. Frederick, Sarcoidosis, Research, Biology, Fibrosis, Associate, Scar, ACS, Dean (education), Howard University, SAN, Knowledge, University, National academy, Humana, Scleroderma, Business, Small RNA, American Surgical Association, Human, Disease, American College, Neuropilin, ATyr Pharma, Health, Inflammation, Organization, MD Anderson Cancer Center, Systemic scleroderma, College, Howard University Hospital, Abstract, Myelocyte, American Cancer Society, Pharmaceutical industry

Dr. Frederick is President Emeritus of Howard University, having served as President from 2014 to 2023.

Key Points: 
  • Dr. Frederick is President Emeritus of Howard University, having served as President from 2014 to 2023.
  • “We are honored to welcome a distinguished physician executive such as Dr. Frederick as an advisor to aTyr,” said Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer of aTyr.
  • He is also the distinguished Charles R. Drew Professor of Surgery at the Howard University College of Medicine and a practicing cancer surgeon at Howard University Hospital.
  • Dr. Frederick earned a B.S., M.D., and completed his surgical residency training at Howard University Hospital.

Leal Health Partners with the American Cancer Society to Host "Hope in the New Year" Webinar

Retrieved on: 
Monday, January 29, 2024
Hope, Patient, ACS, Knowledge, Cancer, Travel, Caregiver, Community development, Colorectal cancer, Leal, Medicine, American Cancer Society, Pharmaceutical industry

Emphasizing the pivotal role of patient empowerment, Tim highlighted the invaluable support offered by patient-centric organizations like Leal Health and the American Cancer Society.

Key Points: 
  • Emphasizing the pivotal role of patient empowerment, Tim highlighted the invaluable support offered by patient-centric organizations like Leal Health and the American Cancer Society.
  • The conversation also spotlighted the American Cancer Society's Hope Lodge program, an initiative that provides free lodging and support to cancer patients and their caregivers during treatment.
  • Together - with the American Cancer Society - we look forward to continuing to make strides against cancer and helping more patients in need."
  • "Our American Cancer Society Hope Lodges create a sense of community for cancer patients and their caregivers," said Chloe Lipman, Vice President of Community Development for the American Cancer Society.

Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform

Retrieved on: 
Wednesday, January 17, 2024
Science, Biotechnology, Research, Men, Oncology, Health, Consumer, Clinical Trials, Death, Patient, Prostate cancer, Novo Nordisk Foundation, Diagnosis, Cancer, Risk, PSA, Overdiagnosis, Biopsy, American Cancer Society

Cleveland Diagnostics, Inc. , a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers announced the closing of over $75M in growth capital financing.

Key Points: 
  • Cleveland Diagnostics, Inc. , a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers announced the closing of over $75M in growth capital financing.
  • The financing will accelerate Cleveland Diagnostics’ commercial and corporate development goals.
  • Cleveland Diagnostics’ portfolio of oncology related tests will be expanding beyond prostate cancer into additional indications in 2024.
  • In connection with the financing, Jee will join the Cleveland Diagnostics Board of Directors.

Select Harris Teeter stores host Health Partner Round Up Campaign

Retrieved on: 
Wednesday, January 24, 2024
American Heart Association, Research, Muscular Dystrophy Association, ACS, ALS Association, Partnership, Muscular dystrophy, Cancer, AHA, MDA, ALS, Organization, Cardiovascular disease, American Cancer Society, Pharmaceutical industry

MATTHEWS, N.C., Jan. 24, 2024 /PRNewswire-PRWeb/ -- Harris Teeter announced today the launch of its Health Partner Round Up Campaign to benefit six leading health non-profit organizations, including: American Cancer Society (ACS), American Heart Association (AHA), ALS Association, JDRF Diabetes Foundation, Muscular Dystrophy Association (MDA) and former Carolina Panther Greg Olsen's foundation, the HEARTest Yard. In 2023, this campaign raised more than $900,000 in total.

Key Points: 
  • MATTHEWS, N.C., Jan. 24, 2024 /PRNewswire-PRWeb/ -- Harris Teeter announced today the launch of its Health Partner Round Up Campaign to benefit six leading health non-profit organizations, including: American Cancer Society (ACS), American Heart Association (AHA), ALS Association, JDRF Diabetes Foundation, Muscular Dystrophy Association (MDA) and former Carolina Panther Greg Olsen's foundation, the HEARTest Yard.
  • North Carolina and South Carolina stores will also benefit the HEARTest Yard in addition to the ones listed above.
  • The funds collected throughout the campaign will be evenly distributed among the health charity partners.
  • These donations are critical for these organizations to continue conducting research and providing life-saving treatments and programs," said Danna Robinson, director of corporate affairs for Harris Teeter.

Haute Residence and Joyce Rey Continue Their Real Estate Partnership Into Eighth Year

Retrieved on: 
Friday, January 19, 2024
Social media, UNICEF USA, National Association of Realtors, REAL, Harold Lloyd Estate, Sale, Los Angeles Times, The Wall Street Journal, Music, ELLE, Real estate, Today, Residence, Marketing, Entertainment News, Organic, UNICEF, Variety, Negotiation, Woman, Onassis, Coldwell Banker, Collegiate summer baseball, Blue ribbon, Homelessness, American Cancer Society, NBC, Partnership, Los Angeles County, California, Estate (law), CNN, Publication

BEVERLY HILLS, Calif., Jan. 19, 2024 /PRNewswire-PRWeb/ -- Referred to as the "Billionaire's Broker" by ELLE, "First Lady of Luxury Real Estate" by the Chinese media, and "Grand Dame of Real Estate" by the Los Angeles Times—Joyce Rey is an icon in her own right. After more than four decades working in the highest echelons of international luxury real estate, she has amassed more than $6 billion in career sales and a roster of celebrity clients who revere her discretion. Negotiating historic estates is her specialty. She is known for marketing and selling some of the most expensive properties in the United States, including the esteemed Perenchio Estate, "Chartwell," in Bel Air. Each year, she breaks sales records—including her own.

Key Points: 
  • Haute Residence and acclaimed real estate agent Joyce Rey take their partnership into its eighth year.
  • As a Haute Residence member, Joyce is one of the agents who exclusively represents the high-end real estate market in Beverly Hills, California.
  • After more than four decades working in the highest echelons of international luxury real estate, she has amassed more than $6 billion in career sales.
  • Joyce's legendary rise in Los Angeles luxury real estate began in 1974, after her first sale—the estate of Christina Onassis.